Statement from Janet Woodcock, M.D., director of FDA’s Center for Drug Evaluation and Research on new testing results, including low levels of impurities in ranitidine drugs

0
5

Statement from Janet Woodcock, M.D., director of FDA’s Center for Drug Evaluation and Research on new testing results, including low levels of impurities in ranitidine drugs

LEAVE A REPLY

Please enter your comment!
Please enter your name here